1. Home
  2. REVB vs LXEH Comparison

REVB vs LXEH Comparison

Compare REVB & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.86

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Lixiang Education Holding Co. Ltd.

LXEH

Lixiang Education Holding Co. Ltd.

HOLD

Current Price

$0.24

Market Cap

4.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
LXEH
Founded
2020
2001
Country
United States
China
Employees
N/A
192
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
REVB
LXEH
Price
$0.86
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
99.4K
174.5K
Earning Date
11-06-2025
12-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,585,942.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.22
52 Week High
$60.48
$50.08

Technical Indicators

Market Signals
Indicator
REVB
LXEH
Relative Strength Index (RSI) 36.34 29.00
Support Level $0.93 $0.22
Resistance Level $0.90 $0.31
Average True Range (ATR) 0.07 0.02
MACD -0.01 0.01
Stochastic Oscillator 3.46 12.88

Price Performance

Historical Comparison
REVB
LXEH

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: